Assessing the risk of second malignancies after modern radiotherapy
about
A Review of Radiotherapy-Induced Late Effects Research after Advanced Technology TreatmentsNew approaches to radiation protectionProton radiobiologyPediatric Exposures to Ionizing Radiation: Carcinogenic ConsiderationsCDDO-Me protects normal lung and breast epithelial cells but not cancer cells from radiationHighly effective treatment of skull base chordoma with carbon ion irradiation using a raster scan technique in 155 patients: first long-term results.Does Proton Therapy Have a Future in CNS Tumors?Paediatric head CT scan and subsequent risk of malignancy and benign brain tumour: a nation-wide population-based cohort studyResveratrol and cancer: focus on in vivo evidence.New challenges in high-energy particle radiobiology.Crosstalk between telomere maintenance and radiation effects: A key player in the process of radiation-induced carcinogenesis.ADVANTAGES OF MCNPX-BASED LATTICE TALLY OVER MESH TALLY IN HIGH-SPEED MONTE CARLO DOSE RECONSTRUCTION FOR PROTON RADIOTHERAPY.Assessment of uncertainties in radiation-induced cancer risk predictions at clinically relevant doses.Benchmarking and validation of a Geant4-SHADOW Monte Carlo simulation for dose calculations in microbeam radiation therapy.Implementation of an analytical model for leakage neutron equivalent dose in a proton radiotherapy planning system.Analytical model for out-of-field dose in photon craniospinal irradiationThe physics of proton therapy.Visualization of risk of radiogenic second cancer in the organs and tissues of the human body.Risk-optimized proton therapy to minimize radiogenic second cancers.Reducing the cost of proton radiation therapy: the feasibility of a streamlined treatment technique for prostate cancer.A simple and fast physics-based analytical method to calculate therapeutic and stray doses from external beam, megavoltage x-ray therapy.The future workforce in cancer prevention: advancing discovery, research, and technology.In silico nanodosimetry: new insights into nontargeted biological responses to radiationBiophysical characterization of a relativistic proton beam for image-guided radiosurgery.Acute DNA damage activates the tumour suppressor p53 to promote radiation-induced lymphomaCan We Spare the Pancreas and Other Abdominal Organs at Risk? A Comparison of Conformal Radiotherapy, Helical Tomotherapy and Proton Beam Therapy in Pediatric Irradiation.The antioxidant tempol reduces carcinogenesis and enhances survival in mice when administered after nonlethal total body radiation.Impact of Charged Particle Exposure on Homologous DNA Double-Strand Break Repair in Human Blood-Derived Cells.Second malignant neoplasms following radiotherapy.Standardized treatment planning methodology for passively scattered proton craniospinal irradiation.Hodgkin's lymphoma emerging radiation treatment techniques: trade-offs between late radio-induced toxicities and secondary malignant neoplasms.Comparative Risk Predictions of Second Cancers After Carbon-Ion Therapy Versus Proton TherapySex-dependent differences in intestinal tumorigenesis induced in Apc1638N/+ mice by exposure to γ rays.EURADOS strategic research agenda: vision for dosimetry of ionising radiation.Influence of acute hypoxia and radiation quality on cell survivalHelical tomotherapy in children and adolescents: dosimetric comparisons, opportunities and issuesRisk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer.Diffusible Factors Secreted by Glioblastoma and Medulloblastoma Cells Induce Oxidative Stress in Bystander Neural Stem Progenitors.Lnk adaptor suppresses radiation resistance and radiation-induced B-cell malignancies by inhibiting IL-11 signaling.Modeling the risk of secondary malignancies after radiotherapy.
P2860
Q26767255-E3111801-E210-4383-A214-25B2D84059F0Q27005588-8595D7B9-C680-48C2-8850-520BFC4BE2BAQ27025061-0E0DA113-1A37-4A9A-80EE-7944F4991654Q28070290-872D519E-6E05-4D70-8B29-51BD58235719Q28542835-0CEE73ED-6DEA-478C-9F4C-9D2A2C2E2197Q33275303-0DA346F8-B37C-43B9-9249-3489A3C0DD3FQ33276436-E09E2F7D-4521-4F98-9C5D-3EBEFE414AD3Q33555187-56FEC85D-A8EA-4ED4-B202-B71838790D40Q33578943-5A9B8004-D7AF-41B2-BDD3-F162B2E26058Q33782346-5778FAEB-546C-43EE-8D5D-E7FDBCA2784DQ33990112-32C582BB-C15B-4C59-B967-3E21D6BCF3EBQ34575096-C9E2FD52-316A-469A-AC89-2E7174FABDDCQ34744993-B4CBABF3-9812-4BCF-87F5-FA651EA8CE73Q35157169-7C3E442F-9EBC-4E7E-BC35-1D2A2FD8116BQ35237533-A3E24D97-821C-4E2D-961D-3CD653AB53E3Q35398974-402709B0-2A7F-4015-AE1B-8C610588EC88Q35531022-C33D7044-9913-4E4B-BF8F-299264F946E7Q35576919-24B2179C-5212-4860-9787-22C7E7A46E69Q35646914-9D756881-7EA4-452D-B4EB-813D4C7474B7Q35818426-A11789B0-9081-4C9F-93B2-96AAAFE243B8Q35835609-89B3FE97-6778-4FC4-9EEF-504063FA7FB7Q35951633-285FE395-4587-4AEA-B616-E1DF963515E9Q36021668-47C525F3-09D9-474B-809C-6475610D404EQ36086184-958DA39C-8420-4285-9B71-74F42E2AF9F9Q36100460-7083A133-1915-48F2-83E7-C44132427B49Q36169085-0107A3EA-1F7B-47B2-A005-6AB384E5F1B1Q36243692-D1D239E1-7963-4CDA-B2D6-A5B77AC8870AQ36270627-FBC408B3-8120-4CB8-8237-C4A81DA348FFQ36538754-E2FCF79F-7AEB-4D04-9B54-32A14C1A131AQ36710649-A68D7708-8DE6-4EC2-A2E7-2FCB1238B860Q36808805-E695CFFF-81BE-4054-AABE-CD5B1BAB8387Q36833350-59B79929-1C7F-444C-9271-445E6466F8C1Q36946119-9358E5C8-251F-43E2-94B5-FF91D4D5F022Q36946368-839DB97C-D2D0-4002-B27D-4EC74767CE94Q36979676-239F04C1-34F4-4AF3-A6BB-85866B3198EAQ37148163-B0C7ED1C-E7DD-4E53-9C1B-D2D426082E37Q37169653-2E47BFD8-6D4A-4B02-A948-F98B9814D146Q37174083-018808EE-B4CC-4E14-8A63-48BF63D9CF59Q37409325-26E3F0A5-2638-4564-AB06-A86AB8CBE3BEQ37590488-939DE63C-9A4C-44A7-9CC6-898F741E82EC
P2860
Assessing the risk of second malignancies after modern radiotherapy
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Assessing the risk of second malignancies after modern radiotherapy
@ast
Assessing the risk of second malignancies after modern radiotherapy
@en
type
label
Assessing the risk of second malignancies after modern radiotherapy
@ast
Assessing the risk of second malignancies after modern radiotherapy
@en
prefLabel
Assessing the risk of second malignancies after modern radiotherapy
@ast
Assessing the risk of second malignancies after modern radiotherapy
@en
P2860
P356
P1476
Assessing the risk of second malignancies after modern radiotherapy
@en
P2093
Wayne D Newhauser
P2860
P2888
P304
P356
10.1038/NRC3069
P407
P577
2011-05-19T00:00:00Z
P5875
P6179
1041361120